MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling by Engelman Jeffrey A, Zejnullahu Kreshnik, Mitsudomi Tetsuya, Song Youngchul, Hyland Courtney, Park Joon Oh, Lindeman Neal, Gale Christopher-Michael, Zhao Xiaojun, Christensen James, Kosaka Takayuki, Holmes Alison J, Rogers Andrew M, Cappuzzo Federico, Mok Tony, Lee Charles, Johnson Bruce E, Cantley Lewis C, Jänne Pasi A in Science (New York, N.Y.) (2007).

[PMID: 17463250] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.